Clinical trials
Phase 1 Venous Thromboembolism trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 6 |
| Terminated | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Utah | 4 |
| Bristol-Myers Squibb | 2 |
| Thomas Jefferson University | 2 |
| Altor BioScience | 1 |
| Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. | 1 |
| BiO2 Medical | 1 |
| Case Comprehensive Cancer Center | 1 |
| City Therapeutics | 1 |
| Daiichi Sankyo | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Venous Thromboembolism | 28 |
| Pulmonary Embolism | 13 |
| Venous Thrombosis | 11 |
| Thromboembolism | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Embolism and Thrombosis | 2 |
| Neoplasms | 2 |
| Thrombosis | 2 |
| Brain Injuries, Traumatic | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 51 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.